User profiles for Andrew Lotery
 | Andrew LoteryProfessor of Ophthalmology, University of Southampton Verified email at soton.ac.uk Cited by 59597 |
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease
We performed a meta-analysis of 14 genome-wide association studies of coronary artery
disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of …
disease (CAD) comprising 22,233 individuals with CAD (cases) and 64,762 controls of …
A large genome-wide association study of age-related macular degeneration highlights contributions of rare and common variants
Advanced age-related macular degeneration (AMD) is the leading cause of blindness in the
elderly, with limited therapeutic options. Here we report on a study of >12 million variants, …
elderly, with limited therapeutic options. Here we report on a study of >12 million variants, …
Retinal gene therapy in patients with choroideremia: initial findings from a phase 1/2 clinical trial
Background Choroideremia is an X-linked recessive disease that leads to blindness due to
mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed …
mutations in the CHM gene, which encodes the Rab escort protein 1 (REP1). We assessed …
Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial
PURPOSE: To compare the efficacy and safety of ranibizumab and bevacizumab intravitreal
injections to treat neovascular age-related macular degeneration (nAMD). DESIGN: …
injections to treat neovascular age-related macular degeneration (nAMD). DESIGN: …
Alternative treatments to inhibit VEGF in age-related choroidal neovascularisation: 2-year findings of the IVAN randomised controlled trial
Background Bevacizumab has been suggested to have similar effectiveness to ranibizumab
for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in …
for treatment of neovascular age-related macular degeneration. The Inhibition of VEGF in …
A single EFEMP1 mutation associated with both Malattia Leventinese and Doyne honeycomb retinal dystrophy
Malattia Leventinese (ML) and Doyne honeycomb retinal dystrophy (DHRD) refer to two
autosomal dominant diseases characterized by yellow-white deposits known as drusen that …
autosomal dominant diseases characterized by yellow-white deposits known as drusen that …
Common variants near CAV1 and CAV2 are associated with primary open-angle glaucoma
…, K Thordarson, M Zhang, C Wadelius, AJ Lotery… - Nature …, 2010 - nature.com
We conducted a genome-wide association study for primary open-angle glaucoma (POAG)
in 1,263 affected individuals (cases) and 34,877 controls from Iceland. We identified a …
in 1,263 affected individuals (cases) and 34,877 controls from Iceland. We identified a …
[HTML][HTML] Prevalence of age-related macular degeneration in Europe: the past and the future
…, M Le Goff, S Leal, Y Lechanteur, T Lehtimäki, A Lotery… - Ophthalmology, 2017 - Elsevier
Purpose Age-related macular degeneration (AMD) is a frequent, complex disorder in elderly
of European ancestry. Risk profiles and treatment options have changed considerably over …
of European ancestry. Risk profiles and treatment options have changed considerably over …
Genome-wide meta-analysis identifies 127 open-angle glaucoma loci with consistent effect across ancestries
Primary open-angle glaucoma (POAG), is a heritable common cause of blindness world-wide.
To identify risk loci, we conduct a large multi-ethnic meta-analysis of genome-wide …
To identify risk loci, we conduct a large multi-ethnic meta-analysis of genome-wide …
Genome-wide association analyses identify multiple loci associated with central corneal thickness and keratoconus
Central corneal thickness (CCT) is associated with eye conditions including keratoconus and
glaucoma. We performed a meta-analysis on >20,000 individuals in European and Asian …
glaucoma. We performed a meta-analysis on >20,000 individuals in European and Asian …
